Fritz Roller

Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial

Mathias Rummel, N. Niederle, Georg Maschmeyer et al. · The Lancet · 2013 · 1.5K citations

Lymphoid Neoplasia, Rituximab Versus Chop, Oncology +10

Validation of the Tricuspid Annular Plane Systolic Excursion/Systolic Pulmonary Artery Pressure Ratio for the Assessment of Right Ventricular-Arterial Coupling in Severe Pulmonary Hypertension

Khodr Tello, Jun Wan, Antonia Dalmer et al. · Circulation Cardiovascular Imaging · 2019 · 537 citations · Full text

Reserve of Right Ventricular-Arterial Coupling in the Setting of Chronic Overload

Khodr Tello, Antonia Dalmer, Jens Axmann et al. · Circulation Heart Failure · 2019 · 250 citations

Bendamustine Plus Rituximab Is Superior in Respect of Progression Free Survival and CR Rate When Compared to CHOP Plus Rituximab as First-Line Treatment of Patients with Advanced Follicular, Indolent, and Mantle Cell Lymphomas: Final Results of a Randomized Phase III Study of the StiL (Study Group Indolent Lymphomas, Germany).

Mathias Rummel, N. Niederle, Georg Maschmeyer et al. · Blood · 2009 · 157 citations

Cardiac Magnetic Resonance Imaging-Based Right Ventricular Strain Analysis for Assessment of Coupling and Diastolic Function in Pulmonary Hypertension

Khodr Tello, Antonia Dalmer, Rebecca Vanderpool et al. · JACC. Cardiovascular imaging · 2019 · 113 citations

Hypertension, Pulmonary Arterial Hypertension, Pulmonary Circulation +9